Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

neurodegenerative diseases/prolina

O link é salvo na área de transferência
ArtigosTestes clínicosPatentes
9 resultados

Proline or proline derivatives for the treatment of dementia

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The invention relates to pharmaceutical composition comprising proline derivatives, preferably Cis-4-hydroxy-I-proline (CHP) and trans-4-Hydroxy-L-proline (THP), or proline, or their salts, esters, isomers, racemates, enantiomers or pro-drugs thereof, and to the use of said compositions for the

Therapeutic proline derivatives

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to proline derivatives useful as pharmaceutical agents, to processes for their production, to pharmaceutical compositions containing them, and to their use for the treatment of the conditions set out below. BACKGROUND TO THE INVENTION Gabapentin

Co-crystal forms of a novobiocin analog and proline

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND Approximately 26 million Americans are afflicted with either Type 1 or Type 2 diabetes. Despite the use of insulin and oral anti-diabetic medications to help maintain euglycemia, about 60-70% of these individuals develop diabetic peripheral neuropathy (DPN). See Veves, A.; Backonja, M.;

Structural mimetics of proline-rich peptides and the pharmaceutical use thereof

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This is the U.S. national stage of International application PCT/DE2007/001768, filed Sep. 25, 2007 designating the United States and claiming priority to European Applications EP 0609078.2, filed Sep. 25, 2006; EP 06090179.0, filed Sep. 25, 2006; and EP 07090095.6, filed May 7, 2007 and German

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
CROSS-REFERENCE TO RELATED APPLICATIONS The present application is a 35 U.S.C. .sctn.371 National Stage patent application of International patent application PCT/AT2009/000071, filed on Feb. 23, 2009, which claims priority to Austria patent application A297/2008, filed on Feb. 22, 2008. The present

Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF INVENTION The present invention relates to substances and compositions for the prevention and treatment of diseases or pathological states related to the degradation of the extracellular matrix, such as including but not limited to degenerative diseases, particularly arteriosclerosis,

Analogs of glycyl-prolyl-glutamate

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION The present invention relates to novel analogs of Glycyl-Prolyl-Glutamate (GPE) and methods of their use. Additionally, this invention relates to the use of these compounds and pharmaceutical compositions thereof in the treatment of diseases and conditions characterised by

Antibodies for the selective determination of procalcitonin 1-116

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
CROSS REFERENCE TO RELATED APPLICATIONS This application is a 371 filing of PCT International application no. PCT/EP2008/001373 filed Feb. 21, 2008 and published in English as WO 2008/104321 A1 on Sep. 4, 2008, which claims the priority of German application no. 102007009751.6 filed Feb. 28, 2007.
The invention relates to the area of medical diagnosis, in particular the determination of biomarkers in biological fluids by means of immunodiagnostic methods. More precisely, the invention relates to the determination of the peptide procalcitonin for diagnostic purposes, a selective measured value
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge